MT treatment in the <i>in vivo</i> OS animal model decreased body weight and increased tumor size. by Jir-You Wang (117926)

“…The results showed that MT (+) group showed decreased body weight (E, 30.5±0.65 g, ▪) and increased tumor volume (F, 8.3±1.18 mm³, ▪) compared to MT (−) group with body weight (E, 35.8±0.40 g, □) and tumor volume (F, 3.9±1.34 mm³, □), respectively. (*, p<0.05 compare with MT (+) versus MT (−) groups).…”

Changes in cyanobacteria fluorescence with 75 μg/mL H₂O₂ for 5, 8, 17 and 24 days. by Emma T. Brentjens (17295999)

Decreased Ly6G⁺ neutrophils in the presence of PLD inhibitors using IF microscopy of lung sections. by Karen M. Henkels (3350273)

“…<p>Lung sections from MDA-MB-231 xenotransplanted mice were incubated with a TRITC-Ly6G antibody specific for TANs (<b>A-D</b>) or biological duplicates from independent experiments stained with Ly6G-R-PE (<b>A’-D’</b>) TANs (<b>A-D</b>) or biological duplicates from independent experiments stained with Ly6G-R-PE or with an isotype control-R-PE IgG antibody (<b>E-H</b>). …”

Treatment with SMIFH2 ablates formation of the cortical granule free domain (CGFD) and decreases the cortical tropomyosin levels. by Hak-Cheol Kim (716627)

Oxfendazole (OFZ) decreases the number of <i>O</i>. <i>ochengi</i> motile male worms and their viability. by Fidelis Cho-Ngwa (191165)

Generation of <i>Slc35a3</i>^–/–mice using genome editing. by Soichiro Saito (15285875)

Triomics Analysis of Imatinib-Treated Myeloma Cells Connects Kinase Inhibition to RNA Processing and Decreased Lipid Biosynthesis by Susanne B. Breitkopf (1496563)

Triomics Analysis of Imatinib-Treated Myeloma Cells Connects Kinase Inhibition to RNA Processing and Decreased Lipid Biosynthesis by Susanne B. Breitkopf (1496563)

Triomics Analysis of Imatinib-Treated Myeloma Cells Connects Kinase Inhibition to RNA Processing and Decreased Lipid Biosynthesis by Susanne B. Breitkopf (1496563)

Gal-9 treatment decreases levels of MMP-9, MMP-2 and TIMP-1 but not neutrophil chemoattractants in BALF. by Yuko Horio (4243405)

Triomics Analysis of Imatinib-Treated Myeloma Cells Connects Kinase Inhibition to RNA Processing and Decreased Lipid Biosynthesis by Susanne B. Breitkopf (1496563)

Improvement of the eye morphology and the motor performance phenotypes of FRDA flies by decreased expression of genes implicated in iron homeostasis. by Sirena Soriano (348274)

Triomics Analysis of Imatinib-Treated Myeloma Cells Connects Kinase Inhibition to RNA Processing and Decreased Lipid Biosynthesis by Susanne B. Breitkopf (1496563)

Table_5_A cross-sectional study on the nasopharyngeal microbiota of individuals with SARS-CoV-2 infection across three COVID-19 waves in India.XLSX by Tungadri Bose (680564)

“…In general, we observed a decrease in the burden of opportunistic pathogens in the host microbiota during the later waves of infection.…”

Image_5_A cross-sectional study on the nasopharyngeal microbiota of individuals with SARS-CoV-2 infection across three COVID-19 waves in India.TIF by Tungadri Bose (680564)

“…In general, we observed a decrease in the burden of opportunistic pathogens in the host microbiota during the later waves of infection.…”

p63^TECko mice have decreased TECs and DN1 cells in embryonic mice. by Heather E. Stefanski (5058746)

Image_1_Dysbiosis of gut microbiota and decreased propionic acid associated with metabolic abnormality in Cushing’s syndrome.jpeg by Qin Zhang (58638)

“…</p>Methods<p>A total of 23 patients with Cushing’s syndrome (18 female and 5 men, aged 47.24 ± 12.99 years) and 30 age-, sex-and BMI-matched healthy controls (18 female and 12 men, aged 45.03 ± 6.69 years) were consecutively recruited. …”

shRNA knockdown of ADAM10 decreases constitutive, PMA-mediated and ionomycin-mediated CAR ECD shedding. by Nadia Houri (451445)

“…With anti-ADAM10 shRNA, there was a significant decrease (40%) in the levels of shed CAR. …”

Decreased antihyperglycemic drug use driven by high out-of-pocket costs despite Medicare coverage gap closure by Mugdha Gokhale (8676201)

“…Re-initiation was lowest in the months before January (HR=0.4-0.5) among non-subsidized DPP-4i patients, demonstrating a strong seasonal pattern. …”

Inhibition of TRPC3 decreases ATP- and OAG-induced Ca²⁺ transients in striatal astrocytes. by Karin M. Streifel (653838)

“…Prior treatment with Pyr3 for 30 minutes at 37°C decreased the Ca²⁺ response to ATP, whereas only a modest additive effect was observed with Pyr3 in the presence of 10 µM MPP⁺. …”